Understanding Long Covid Pain in Primary Care
Determination and Characterization of Persistent Musculoskeletal Pain in Covid-19 Patients in Primary Care.
This study is trying to understand ongoing pain in people who have recovered from Covid-19 by looking at how common it is and comparing those with pain to those without.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Valladolid Academic / other |
| Locations | 1 site (Valladolid) |
| Trial ID | NCT05894642 on ClinicalTrials.gov |
What this trial studies
This observational study aims to characterize persistent musculoskeletal pain in patients who have recovered from Covid-19. It will be conducted in two phases: first, a descriptive cross-sectional study to estimate the prevalence of Long Covid Pain (LCP), followed by a case-control study comparing patients with LCP to those without persistent pain. The study will assess various factors, including central sensitization, to better understand the underlying mechanisms of pain in this population.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18-70 who have had a confirmed Covid-19 infection and are experiencing musculoskeletal pain lasting more than 12 weeks.
Not a fit: Patients with a history of chronic musculoskeletal pain prior to Covid-19 or those with specific exclusions such as major depression or fibromyalgia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the prevalence and mechanisms of Long Covid Pain, leading to improved management strategies for affected patients.
How similar studies have performed: While there is limited literature on the specific characterization of Long Covid Pain, similar studies on post-viral syndromes have shown promise in understanding chronic pain mechanisms.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have had Covid-19, with a confirmatory PCR+ test or positive antigen test and recorded in their primary care medical record. * Subjects between 18-70 years old. * Musculoskeletal pain of more than 12 weeks of evolution since the beginning of the infection. * Agree to participate in the study and sign the informed consent form. Exclusion Criteria: * History of chronic musculoskeletal pain of more than 12 weeks of evolution prior to Covid-19. * History of diagnosed major depression. * Having a diagnosis of fibromyalgia prior to Covid-19 infection. * Pregnancy. * Pain of oncologic origin. * Fracture or surgical intervention on the spine in the last year. * Bladder or bowel incontinence. * Saddle anesthesia.
Where this trial is running
Valladolid
- Universidad de Valladolid — Valladolid, Spain (Recruiting)
Study contacts
- Study coordinator: Federico Montero Cuadrado
- Email: montercua1981@hotmail.com
- Phone: +34651529993
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.